Nu-Med Plus (NUMD) Share-based Compensation Growth (3y) (2015 - 2022)
Nu-Med Plus (NUMD) Share-based Compensation Growth (3y) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 3.40% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -11.21% |
| Dec 31, 2021 | -19.27% |
| Mar 31, 2021 | 143.77% |
| Dec 31, 2020 | -198.68% |
| Sep 30, 2020 | 51.93% |
| Dec 31, 2019 | -55.42% |
| Sep 30, 2019 | 30.60% |
| Jun 30, 2019 | -63.16% |
| Dec 31, 2018 | 16.57% |
| Sep 30, 2018 | 6.29% |
| Mar 31, 2018 | 396.31% |
| Dec 31, 2017 | -27.05% |
| Sep 30, 2017 | -49.98% |
| Sep 30, 2016 | -90.25% |
| Dec 31, 2015 | -131.98% |
| Sep 30, 2015 | 150.53% |